Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: Deciphering the role of neutrophils to radiation response in pancreatic ductal adenocarcinoma (PDAC).
Methods: Using a murine model of PDAC, mice were treated with a clinically- relevant regime of targeted stereotactic body radiation therapy (SBRT). Neutrophil infiltration and activation status were assessed by flow cytometry and immunohistochemistry. Depletion studies were used to determine their role in overall treatment response. Finally, microspheres containing IL-12 cytokine were employed following SBRT to therapeutically repolarize these cells.
Results: Following SBRT, neutrophils infiltrated PDAC tumors in high numbers and largely exhibited an immunosuppressive phenotype. Depletion studies confirmed their role in acquired radioresistance, as SBRT efficacy was improved in their absence. Delivering IL-12 cytokine following SBRT could repolarize these cells to be immunostimulatory and enhance anti-tumor immunity in this model.
Conclusion: Neutrophils are key players in SBRT and IL-12 treatment and can act as a double-edged sword depending on the treatment employed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ijrobp.2025.06.3853 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Stereotactic Body Radiation Therapy for Epidural Spinal Cord Compression: Treat Aggressively Now, Avoid Recurrence Later.
Int J Radiat Oncol Biol Phys
October 2025
Department of Central Nervous System Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Urinary organs-at-risk for radiotherapy following radical prostatectomy: contouring guidelines on behalf of the Francophone Group of Urological Radiation Therapy (GFRU).
Pract Radiat Oncol
September 2025
Department of Radiation Oncology, Institut Bergonié, Bordeaux, France; Centre de Radiothérapie Charlebourg, La Défense, Groupe Amethyst, 65, avenue Foch, 92250 La Garenne-Colombes, France.
Purpose: Urinary toxicity following radical prostatectomy (RP) and postoperative radiotherapy (RT) includes urinary incontinence and vesicourethral anastomosis (VUA) strictures. With the increasing use of stereotactic body radiotherapy (SBRT), dose-escalation, and reirradiation within the prostate bed (PB), standardization of the definition of urinary organs at risk (OARs) in the post-RP setting is needed. This works aims to provide a comprehensive review of the anatomical and physiopathological changes occurring after RP, as well as to provide a consensus on urinary OARs delineation for prostate cancer (PCa) EBRT in the post-RP setting.
View Article and Find Full Text PDFStereotactic Body Radiation Therapy Facilitating Debulking Surgery in Metastatic VIPoma with Severe Diarrhea and Hypovolemic Shock.
Am J Case Rep
September 2025
Department of Hematology Oncology, University of Illinois, Chicago, IL, USA.
BACKGROUND Treatment of metastatic vasoactive intestinal peptide tumors (VIPoma) is challenging and requires a careful multidisciplinary approach to achieve optimal disease control. We present a case of metastatic VIPoma with recurring episodes of life-threatening diarrhea necessitating multiple intensive care unit (ICU) admissions. CASE REPORT A 54-year-old man presented with severe watery diarrhea and metabolic acidosis with MRI showing a necrotic pancreatic body mass, and multiple liver lesions.
View Article and Find Full Text PDFMargin for compensating displacement of adrenal gland metastasis and fiducial marker along with respiratory phase in real-time motion-tracking radiation therapy.
Radiol Phys Technol
September 2025
Radiation and Proton Therapy Center, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-Cho, Shizuoka, 411-8777, Japan.
In therapy with Synchrony® mounted on Radixact®, the fiducial marker (FM) and adrenal gland metastasis, which shift with respiratory phase, require margin compensation for high-dose prescriptions. Although compensation is critical, no studies have examined the margin to compensate for the respiratory phase shift. Therefore, we aimed to suggest the compensating margin for the FM and adrenal metastasis shift along with respiratory phase.
View Article and Find Full Text PDFDosimetric Outcomes of SBRT to Ultra-central Lung Tumors: Lessons from the SUNSET trial.
Int J Radiat Oncol Biol Phys
September 2025
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. Electronic address:
Purpose / Introduction: The BLINDED FOR REVIEW trial investigated the maximum tolerated dose for ultracentral lung tumors treated with stereotactic body radiotherapy (SBRT). Here we report a spatial and dosimetric secondary analysis of the treatment plans and assess relationships between doses to targets, organs-at-risk (OARs) and clinical outcomes.
Material And Methods: Five institutions enrolled patients with ultracentral lung cancer, cT1-3N0M0, and all received 60 Gy in 8 fractions.